Safety and tolerability of adjunctive eslicarbazepine acetate in adolescents with focal-onset seizures: Data from three double-blind, placebo-controlled randomized clinical studies

被引：0
|
作者：
Garcia-Penas, Juan-Jose [1 ]
Ikedo, Fabio [2 ]
Fonseca, Miguel [2 ]
Fernandez, Guillermo Castilla [2 ]
Pereira, Ana [2 ]
Moreira, Joana [2 ]
Gama, Helena [2 ]
机构：
[1] Nino Jesus Pediat Univ Hosp, Epilepsy Unit, Neuropediat Sect, Madrid, Spain
[2] BIAL Portela & Ca SAS Mamede Coronado, Div Res & Dev, Porto, Portugal
来源：
JOURNAL OF THE NEUROLOGICAL SCIENCES | 2021年 / 429卷
关键词：
D O I：
10.1016/j.jns.2021.119157
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
119157
引用
收藏
页码：159 / 160
页数：2
相关论文
共 50 条
  • [21] EFFICACY, SAFETY, AND TOLERABILITY OF CARISBAMATE 800 AND 1200 MG/DAY AS ADJUNCTIVE THERAPY IN PATIENTS WITH PARTIAL ONSET SEIZURES; RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
    Halford, J. J.
    Ben-Menachem, E.
    Kwan, P.
    Ness, S.
    Schmitt, J.
    Eerdekens, M.
    Novak, G.
    EPILEPSIA, 2010, 51 : 14 - 15
  • [22] Long-term safety and tolerability of eslicarbazepine acetate in an Asian adult population with focal seizures: Results from a randomized, double blind, placebo-controlled study with two open label parts
    Ikedo, F.
    Fernandez, G. C.
    Fonseca, M. M.
    Pereira, A.
    Moreira, J.
    Grinnell, T.
    Gama, H.
    EPILEPSIA, 2022, 63 : 72 - 73
  • [23] Efficacy and Safety of Eslicarbazepine Acetate as add-on Treatment in Adult Patients with Focal-Onset Seizures by Concomitant Antiepiletic Drug: Data from Four Double-Blind Pivotal Phase III Studies
    Chaves, Joao
    Loureiro, Rui
    Moreira, Joana
    Ikedo, Fabio
    Fernandes, Helder
    NEUROLOGY, 2020, 94 (15)
  • [24] Eslicarbazepine acetate: A double-blind, add-on, placebo-controlled exploratory trial in adult patients with partial-onset seizures
    Elger, Christian
    Bialer, Meir
    Cramer, Joyce A.
    Maia, Joana
    Almeida, Luis
    Soares-da-Silva, Patricio
    EPILEPSIA, 2007, 48 (03) : 497 - 504
  • [25] Efficacy and safety of cenobamate as adjunctive therapy in patients with uncontrolled focal seizures: results from two double-blind, placebo-controlled, international studies
    Steinhoff, B. J.
    Sanchez-Alvarez, J.
    Majkowska-Zwolinska, B.
    Maciejowski, M.
    Villanueva, V.
    Brandt, C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 60 - 60
  • [26] Efficacy and tolerability of almotriptan in adolescents: A randomized, double-blind, placebo-controlled trial
    Linder, Steven L.
    Mathew, Ninan T.
    Cady, Roger K.
    Finlayson, Gary
    Ishkanian, Gary
    Lewis, Donald W.
    HEADACHE, 2008, 48 (09): : 1326 - 1336
  • [27] Adjunctive Everolimus Therapy for Treatment-resistant Focal-onset Seizures Associated with Tuberous Sclerosis: A Phase 3, Randomised, Double-blind, Placebo-controlled Study
    Karaoglan, Mustafa
    TURKISH JOURNAL OF NEUROLOGY, 2018, 24 (02) : 193 - 194
  • [28] SAFETY AND TOLERABILITY OF BRIVARACETAM AS ADJUNCTIVE TREATMENT IN ADULTS WITH REFRACTORY EPILEPSY: RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
    Kwan, P.
    Johnson, M. E.
    Falter, U.
    Pietteur, V. B.
    Brodsky, A. C.
    von Rosenstiel, P.
    EPILEPSIA, 2009, 50 : 107 - 108
  • [29] EFFICACY AND SAFETY OF ADJUNCTIVE BRIVARACETAM FOR PARTIAL-ONSET (FOCAL) SEIZURES: POOLED RESULTS FROM THREE FIXED-DOSE, RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE III STUDIES
    Quarato, P. P.
    Whitesides, J.
    D'Souza, J.
    Johnson, M. E.
    Schiemann, J.
    EPILEPSIA, 2015, 56 : 208 - 209
  • [30] EFFICACY AND SAFETY OF PERAMPANEL AS ADJUNCTIVE THERAPY IN ADOLESCENTS WITH REFRACTORY PARTIAL-ONSET SEIZURES: ANALYSIS OF A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE III STUDY
    Villanueva, V.
    Rozentals, G.
    Yang, H.
    Squillacote, D.
    Zhu, J.
    Laurenza, A.
    EPILEPSIA, 2011, 52 : 242 - 242
12345